Showing results (341-350 of 434) with videos related to

Sort By:
Pageof 44
Health Technology Assessment (Winchester, England)|May 29, 2010
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancerN Fleeman, A Bagust, C McLeod, et al.
Health Technology Assessment (Winchester, England)|March 14, 2012
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergyJ Hockenhull, M Elremeli, M G Cherry, et al.
Transplantation|August 15, 1997
Retransplantation of patients with severe posttransplant hepatitis B in the first allograftM Ishitani, R McGory, R Dickson, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
A model to predict survival in patients with end-stage liver diseaseP S Kamath, R H Wiesner, M Malinchoc, et al.
Health Technology Assessment (Winchester, England)|September 13, 2011
The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic reviewN Fleeman, C Martin Saborido, K Payne, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary interventionJ Greenhalgh, A Bagust, A Boland, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancerS Wojtowicz-Praga, J Low, J Marshall, et al.
Health Technology Assessment (Winchester, England)|July 2, 2009
Erlotinib for the treatment of relapsed non-small cell lung cancerC McLeod, A Bagust, A Boland, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitisR H Wiesner, M K Porayko, E R Dickson, et al.
Pageof 44